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Significant Manipulative Procedures to Reduce Immunogenicity 
of Human Islet Allografts 
K. Ulrichs and W. Miiller-Ruchholtz 
SUCCESSFUL TRANSPLANTATION of pancreatic islets will depend on a better knowledge of those cells 
which contribute highly to allograft immunogenicity but not 
to the desired graft function. This knowledge, based upon 
morphologic and functional in vitro data, appears to be 
crucial for a successful reduction of graft immunogenicity. 
MATERIALS AND METHODS 
Immunofluorescence studies and mixed Iymphocyte islet culture 
(MLlC) tests were performed using cryopreserved crude human 
islet preparations l and various HLA- as well as cell type-specific 
monoclonal antibodies in order to (a) locate the potentially immu-
nogenic cells and (b) demonstrate their functional relevance before 
and after antibody incubation. Microscopic evaluation of exocrine 
and endocrine tissue components of crude islet preparations was 
greatly facilitated by the islet-specific dithizone staining tech-
nique.2 
RESULTS 
Immunofluorescence 
Using dithizone counterstaining, the vast majority of MHC 
class II-positive cells was found to be located in the exocrine 
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Fig 1. Human mixed Iymphocyte Islet culture (MLIC): Inhibi-
tion by (A) HLA-DR/ DP monoclonal antibody and (8) rat MHC 
class 11 monoclonal antibody (speclficlty control). Column 
(col.) 1, 10· responder Iymphocytes from peripheral blood + 
medium; col. 2, 40 HLA-mlsmatched, mitomycin C-treated 
stlmulator Islets + medium; col. 3, uninhibited allogeneic 
response as control; col. 4-col. 7, allogeneic response after 
Varying treatment protocols: col. 4, pretreatment of 
. responder cells with HLA-DR / DP antibody TU39 or rat I-E 
~,:,.tlbodY OX17; col. 5, pretreatment of stimulator islets with 
U39 or OX17; col. 6, pretreatment of both responder cells 
and stlmulator Islets; col. 7 permanent presence of the ~s t ' pec Ive antibody during the 5-day culture period. 
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tissue portion; these cells strongly expressed HLA-DR/DP 
but very rarely HLA-DQ. By contrast (and in contrast to 
rodent models), the endocrine tissue portion, ie, pure islets, 
contained only few and very weakly stained HLA-DR/DP 
positive cells. Importantly, and in contrast to our experience 
with rat islets, endocrine beta cells were always HLA-
DR/DP /DQ-negative. 
Mixed Lymphocyte Islet Culture 
Crude islet preparations with 30-40 islets acted as powerful 
stimulators in MHC-allogeneic MUC. By contrast, the 
allogeneic response was markedly reduced when clean, hand-
picked stimulator islets were used. This allogeneic response 
was reduced still more by preincubation of the responder 
lymphocytes and/or the crude islet preparations with HLA-
DR/DP antibodies, as shown in Fig I . 
CONCLUSIONS 
(I) According to the morphologic findings, the predominance 
of MHC class II-positive cells in the exocrine pancreas 
portion, compared with islets, is expressed much more 
strongly in the human than in rodents. (II) According to the 
functional findings, the immunogenicity of these cells can be 
inhibited by an MHC class 11 antibody. (Ill) This functional 
inhibition appears to be more important the less purified the 
islets are-that is, the more they are contaminated by 
exocrine tissue debris. 
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